2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Association of thyroid function with non‐alcoholic fatty liver disease in recent‐onset diabetes

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background and Aims

          Non‐alcoholic fatty liver disease (NAFLD) has been linked to type 2 diabetes (T2D), but also to hypothyroidism. Nevertheless, the relationship between thyroid function and NAFLD in diabetes is less clear. This study investigated associations between free thyroxine (fT4) or thyroid‐stimulating hormone (TSH) and NAFLD in recent‐onset diabetes.

          Methods

          Participants with recent‐onset type 1 diabetes (T1D, n = 358), T2D ( n = 596) or without diabetes (CON, n = 175) of the German Diabetes Study (GDS), a prospective longitudinal cohort study, underwent Botnia clamp tests and assessment of fT4, TSH, fatty liver index (FLI) and in a representative subcohort 1H‐magnetic resonance spectroscopy.

          Results

          First, fT4 levels were similar between T1D and T2D ( p = .55), but higher than in CON (T1D: p < .01; T2D: p < .001), while TSH concentrations were not different between all groups. Next, fT4 correlated negatively with FLI and positively with insulin sensitivity only in T2D ( ß = −.110, p < .01; ß = .126, p < .05), specifically in males ( ß = −.117, p < .05; ß = .162; p < .01) upon adjustments for age, sex and BMI. However, correlations between fT4 and FLI lost statistical significance after adjustment for insulin sensitivity (T2D: ß = −.021, p = 0.67; males with T2D: ß = −.033; p = .56). TSH was associated positively with FLI only in male T2D before ( ß = .116, p < .05), but not after adjustments for age and BMI ( ß = .052; p = .30).

          Conclusions

          Steatosis risk correlates with lower thyroid function in T2D, which is mediated by insulin resistance and body mass, specifically in men, whereas no such relationship is present in T1D.

          Related collections

          Most cited references52

          • Record: found
          • Abstract: found
          • Article: not found

          Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

          NAFLD is one of the most important causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming decades, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NAFLD vary worldwide, usually parallel to the prevalence of obesity, but a substantial proportion of patients are lean. The large number of patients with NAFLD with potential for progressive liver disease creates challenges for screening, as the diagnosis of NASH necessitates invasive liver biopsy. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their need for management. While awaiting the development effective therapies, this disease warrants the attention of primary care physicians, specialists and health policy makers.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.

            (2016)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.

              Liver biopsy remains the gold standard in the assessment of severity of liver disease. Noninvasive tests have gained popularity to predict histology in view of the associated risks of biopsy. However, many models include tests not readily available, and there are limited data from patients with HIV/hepatitis C virus (HCV) coinfection. We aimed to develop a model using routine tests to predict liver fibrosis in patients with HIV/HCV coinfection. A retrospective analysis of liver histology was performed in 832 patients. Liver fibrosis was assessed via Ishak score; patients were categorized as 0-1, 2-3, or 4-6 and were randomly assigned to training (n = 555) or validation (n = 277) sets. Multivariate logistic regression analysis revealed that platelet count (PLT), age, AST, and INR were significantly associated with fibrosis. Additional analysis revealed PLT, age, AST, and ALT as an alternative model. Based on this, a simple index (FIB-4) was developed: age ([yr] x AST [U/L]) / ((PLT [10(9)/L]) x (ALT [U/L])(1/2)). The AUROC of the index was 0.765 for differentiation between Ishak stage 0-3 and 4-6. At a cutoff of 3.25 had a positive predictive value of 65% and a specificity of 97%. Using these cutoffs, 87% of the 198 patients with FIB-4 values outside 1.45-3.25 would be correctly classified, and liver biopsy could be avoided in 71% of the validation group. In conclusion, noninvasive tests can accurately predict hepatic fibrosis and may reduce the need for liver biopsy in the majority of HIV/HCV-coinfected patients.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                Journal
                Liver International
                Liver International
                Wiley
                1478-3223
                1478-3231
                January 2024
                September 12 2023
                January 2024
                : 44
                : 1
                : 27-38
                Affiliations
                [1 ] Institute for Clinical Diabetology, German Diabetes Center Leibniz Institute for Diabetes Research at Heinrich Heine University Düsseldorf Germany
                [2 ] German Center for Diabetes Research (DZD e.V.) München‐Neuherberg Germany
                [3 ] Department of Endocrinology and Diabetology, Medical Faculty Heinrich Heine University, University Hospital Düsseldorf Germany
                [4 ] Institute for Biometrics and Epidemiology, German Diabetes Center Leibniz Institute for Diabetes Research at Heinrich Heine University Düsseldorf Germany
                [5 ] Department of Radiology and Nuclear Medicine Maastricht University Medical Center Maastricht The Netherlands
                Article
                10.1111/liv.15723
                9ad4ece6-27a7-4e99-952a-82aa991133b9
                © 2024

                http://creativecommons.org/licenses/by-nc-nd/4.0/

                History

                Comments

                Comment on this article